Organogenesis Holdings Inc. - Class A (ORGO)
5.1550
-0.4800 (-8.52%)
Organogenesis Holdings Inc is a leading regenerative medicine company that focuses on developing and commercializing advanced wound care and surgical biologics products
The company specializes in innovative solutions that support the healing of complex wounds and surgical procedures, leveraging its expertise in cellular and tissue-based therapies. Organogenesis is committed to improving patient outcomes by offering cutting-edge products that foster healing and recovery, thereby addressing unmet medical needs in the healthcare sector. Through a combination of research, development, and clinical support, the company aims to enhance the quality of care provided to patients across various medical disciplines.
| Previous Close | 5.635 |
|---|---|
| Open | 5.640 |
| Bid | 5.150 |
| Ask | 5.230 |
| Day's Range | 5.013 - 5.705 |
| 52 Week Range | 2.165 - 6.710 |
| Volume | 1,344,533 |
| Market Cap | 676.65M |
| PE Ratio (TTM) | -257.75 |
| EPS (TTM) | -0.0 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 3,900,640 |
